| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/22/2009 | US20090023173 Luminescence-based methods and probes for measuring cytochrome P450 activity |
| 01/22/2009 | US20090022688 Inhibitors of serine protease, particularly hcv ns3-ns4a protease |
| 01/22/2009 | US20090022664 Radiolabelling via fluorination of aziridines |
| 01/22/2009 | DE102007032977A1 Neue Cyclische Amide, Verfahren zu deren Herstellung und ihre Verwendung Novel cyclic amides, process for their preparation and their use |
| 01/22/2009 | CA2695998A1 Novel heterocyclyl compounds |
| 01/22/2009 | CA2694475A1 Quinazolinamide derivatives |
| 01/22/2009 | CA2692713A1 Heterocyclic modulators of pkb |
| 01/21/2009 | EP2017265A1 Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 01/21/2009 | EP2017263A1 Heteroarylamide lower carboxylic acid derivative |
| 01/21/2009 | EP2016073A1 Process for the preparation of pure irbesartan |
| 01/21/2009 | EP2016057A1 C-fms kinase inhibitors |
| 01/21/2009 | EP2016049A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors |
| 01/21/2009 | EP2016047A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP2015751A2 Salts of pyridazine compounds |
| 01/21/2009 | EP1626964B1 New benzimidazole derivatives |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | EP0958291B1 3-heterocyclyl-substituted benzoyl derivatives |
| 01/21/2009 | CN101351459A Method for producing 4(3H)-quinazolinone derivative |
| 01/21/2009 | CN101351453A 杂环酰胺化合物及其用途 The heterocyclic amide compounds and use thereof |
| 01/21/2009 | CN101351446A Novel fused pyrrole derivatives |
| 01/21/2009 | CN101348482A 3-amido-4-indole maleimide compound, preparation and use thereof |
| 01/21/2009 | CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 01/21/2009 | CN100453553C Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/21/2009 | CN100453535C 2-substituted pyrimidines. |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479559 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479502 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
| 01/20/2009 | US7479496 Substituted spiro azabicyclics as modulators of chemokine receptor activity |
| 01/20/2009 | US7479495 N-heterocyclic inhibitors of TNF-α expression |
| 01/20/2009 | US7479471 Applying to plants, seeds |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |
| 01/20/2009 | CA2344411C 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 01/20/2009 | CA2322204C 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 01/15/2009 | WO2009008371A1 Di(arylamino)aryl compound |
| 01/15/2009 | WO2009007986A1 An improved process for the preparation of candesartan cilexetil |
| 01/15/2009 | WO2009007753A2 4- (3-aminopyrazole) -pyrimidine derivativee and their use as tyrosine kinase inhibitors for the treatment of cancer |
| 01/15/2009 | WO2009007390A2 2-pyraz inylbenz imidazole derivatives as receptor tyrosine kinase inhibitors |
| 01/15/2009 | WO2009007187A1 Substituted 5-hetarylpyrimidines |
| 01/15/2009 | WO2009007074A1 Pyrimidinyl pyridazinone derivates |
| 01/15/2009 | WO2009006959A1 Pyridazinone derivates |
| 01/15/2009 | WO2008142140A3 Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| 01/15/2009 | WO2008124083A3 Aurora kinase modulators and method of use |
| 01/15/2009 | WO2008097546A3 Compounds that inhibit cholinesterase |
| 01/15/2009 | WO2008089005A3 Renin inhibitors |
| 01/15/2009 | WO2008076247A3 Nitroderivatives as angiotensin ii receptor antagonists |
| 01/15/2009 | WO2008076246A3 Nitroderivatives as angiotensin ii receptor antagonists |
| 01/15/2009 | WO2007114827A8 Substituted heterocyclic compounds and methods of use |
| 01/15/2009 | WO2006073202A9 METHOD OF TUMOR SUPPRESSION AND EVALUATION OF ANTICANCER AGENT BASED ON GSK3β INHIBITORY EFFECT |
| 01/15/2009 | US20090018344 Process for the preparation of candesartan cilexetil |
| 01/15/2009 | US20090018338 Treatment of CRTH2-Mediated diseases and conditions |
| 01/15/2009 | US20090018144 Capped pyrazinoylguanidine sodium channel blockers |
| 01/15/2009 | US20090018141 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 01/15/2009 | US20090018139 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018138 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018087 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
| 01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
| 01/15/2009 | US20090017330 Material for organic electroluminescence device and organic electroluminescence device utilizing the same |
| 01/15/2009 | US20090017307 Process for the Preparation of Organic Materials |
| 01/15/2009 | US20090017112 Compounds for Inhibiting Beta-Amyloid Production |
| 01/15/2009 | US20090017038 Sigma-2 Receptor, Method of Screening of Specific Ligands and Use of the Same in Diagnostic or Therapeutic Methods |
| 01/15/2009 | CA2693600A1 Pyridazinone derivatives |
| 01/15/2009 | CA2693513A1 An improved process for the preparation of candesartan cilexetil |
| 01/15/2009 | CA2692867A1 Pyrimidinyl-pyridazinone derivatives |
| 01/15/2009 | CA2692611A1 Di(arylamino)aryl compounds |
| 01/15/2009 | CA2690349A1 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 01/14/2009 | EP2014657A1 Diaminopyrimidines as modulators for an EP2 receptor |
| 01/14/2009 | EP2014291A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 01/14/2009 | EP2013200A2 Polyamides for treating human papilloma virus |
| 01/14/2009 | EP2013199A1 Adenosine a3 receptor agonists |
| 01/14/2009 | EP2013185A1 Novel compounds |
| 01/14/2009 | EP2013180A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors |
| 01/14/2009 | EP2012780A2 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
| 01/14/2009 | EP1898917B1 Aminopyrimidines as kinase modulators |
| 01/14/2009 | EP1805146A4 Process for preparing telmisartan |
| 01/14/2009 | EP1622894B1 Antitumoral antiandrogenic pyrrolidines |
| 01/14/2009 | EP1588707B1 Stable solid medicinal composition for oral administration of ramosetron |
| 01/14/2009 | EP1567518B1 Oxime ester photoinitiators with heteroaromatic groups |
| 01/14/2009 | EP1560584B1 Fab i inhibitors |
| 01/14/2009 | EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | CN101346371A 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 01/14/2009 | CN101346370A PDF inhibitors |
| 01/14/2009 | CN101346369A Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 01/14/2009 | CN101343537A Synthesis of novel organic luminescent material containing triphenylethylene carbazole derivant structure and application thereof |
| 01/14/2009 | CN101343251A Thrombopoietin mimetics |
| 01/14/2009 | CN101343250A Thrombopoietin mimetics |
| 01/14/2009 | CN101342169A Thrombopoietin mimetics |
| 01/14/2009 | CN100451016C Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476675 Quinolinone derivatives and uses thereof |
| 01/13/2009 | US7476674 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 01/13/2009 | CA2392902C Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 01/13/2009 | CA2346506C Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 01/13/2009 | CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |